Top

Breast Cancer Research and Treatment

Published in:

01-06-2004

Use of complementary and alternative medicine by Chinese women with breast cancer

Authors: Yong Cui, Xiao-Ou Shu, Yutang Gao, Wanqing Wen, Zhi-Xian Ruan, Fan Jin, Wei Zheng

Published in: Breast Cancer Research and Treatment | Issue 3/2004

Title: Use of complementary and alternative medicine by Chinese women with breast cancer
Authors: Yong Cui
Xiao-Ou Shu
Yutang Gao
Wanqing Wen
Zhi-Xian Ruan
Fan Jin
Wei Zheng
Publication date: 01-06-2004
Publisher: Kluwer Academic Publishers
Published in: Breast Cancer Research and Treatment / Issue 3/2004
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1023/B:BREA.0000025422.26148.8d

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

ACC 2024 Congress

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/2004

Author Index, Volume 85

The influence of clinical information on the accuracy of diagnostic mammography

Decreased secretion of Cathepsin D in breast cancer in vivo by tamoxifen: Mediated by the mannose-6-phosphate/IGF-II receptor?

A Systematic Review of Intraoperative Radiotherapy in Early Breast Cancer

Anastrozole (‘Arimidex’) versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: Results of the double-blind cross-over SAKK trial 21/95 - a sub-study of the TARGET (Tamoxifen or ‘Arimidex’ Randomized Group Efficacy and Tolerability) trial

Phenotypic similarities in bilateral breast cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer